🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Rectal Neuroendocrine Neoplasm

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites📍 Scottsdale📍 La Jolla📍 Stanford BioEclipse Therapeutics · Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide Lateral Pelvic Lymph Node Dissection for Rectal Neuroendocrine Neoplasms Undergoing Laparoscopic Total Mesenteric Excision NCT06279299NA1 site📍 Beijing National Cancer Center, China · Tests: lateral pelvic lymph node dissection A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors NCT07749586Phase 1, Phase 24 sites📍 New York📍 Huntersville📍 San Antonio Arvinas Inc. · Tests: ARV-6723, Pembrolizumab, SOC Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors NCT04771520Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Avapritinib IDOV-Immune for Advanced Solid Tumors NCT06910657Phase 15 sites📍 St Louis📍 Houston📍 San Antonio ViroMissile, Inc. · Tests: IDOV-Immune (oncolytic vaccinia virus) A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors NCT07376707Phase 11 site📍 Shanghai Hefei TG ImmunoPharma Co., Ltd. · Tests: TGI-5 Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS NCT05379985Phase 1, Phase 221 sites📍 Orange📍 Santa Monica📍 Tampa Revolution Medicines, Inc. · Tests: RMC-6236 A Study of IBI363 in Subjects with Advanced Solid Malignancies NCT06281678Phase 29 sites📍 San Francisco📍 Ocala📍 Plantation Innovent Biologics (Suzhou) Co. Ltd. · Tests: IBI363 Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors NCT07552467n/a1 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: Specific PET imaging agents targeting LRRC15 Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" NCT01365169NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Exercise Intervention, Health Telemonitoring, Health Telemonitoring, Health Telemonitoring, Health Telemonitoring TARGETed Therapy Drug MONITOring in DIGestive Oncology NCT05443087NA29 sites📍 Amiens📍 Auxerre📍 Avignon UNICANCER · Tests: Blood sampling to build population pharmacokinetics model Risk Factors for Neuroendocrine Neoplasms NCT06282016n/a1 site📍 Nuremberg Bavarian Cancer Registry · Tests: Case-control study (no intervention) Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05) NCT07327489n/a8 sites📍 Fort Smith📍 Frederick📍 Springfield Elephas · Tests: Biopsy The Florida ASCENT Study NCT07042243NA1 site📍 Gainesville University of Florida · Tests: MyCarePulse and ASCENT PN Social Prescriptions and Micro-Learning to Improve Care for Cancer Patients and Their Support Persons NCT07788729NA8 sites📍 Augsburg📍 Erlangen📍 Regensburg University of Regensburg · Tests: PRISMA-interventions The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas NCT07285044Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Cancer Therapeutic Procedure, Cancer Therapeutic Procedure, Questionnaire Administration Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EBNK-001 + IL-15 + Pembrolizumab A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors NCT05592626Phase 1, Phase 219 sites📍 Sacramento📍 Celebration📍 Miami Marengo Therapeutics, Inc. · Tests: STAR0602, Irinotecan (Camptosar), Docetaxel (Taxotere) ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation NCT05059444n/a57 sites📍 Birmingham📍 Chandler📍 Hot Springs Guardant Health, Inc. · Tests: Guardant Reveal Navigation Intervention for Adolescent and Young Adult Cancer Survivors NCT07406087NA1 site📍 Pasadena Kaiser Permanente · Tests: Adapted patient navigation program targeting adolescent and young adult cancer survivors Sample Collection for Ongoing Research and Product Evaluation Study NCT07318051n/a1 site📍 Austin Natera, Inc. Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors NCT03755739Phase 2, Phase 31 site📍 Guanzhou Second Affiliated Hospital of Guangzhou Medical University · Tests: Checkpoint inhibitor (CPI) such as Pembrolizumab plus chemotherapy A Study of MGC026 in Participants With Advanced Solid Tumors NCT06242470Phase 112 sites📍 Los Angeles📍 Grand Rapids📍 Lake Success MacroGenics · Tests: MGC026 Dose Escalation, MGC026 Dose for Expansion Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer NCT01174121Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Pembrolizumab (Keytruda), Fludarabine, Cyclophosphamide, Aldesleukin, Young TIL Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial NCT04693377NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Cryosurgery, Quality-of-Life Assessment, Stereotactic Body Radiation Therapy A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors NCT07317505Phase 13 sites📍 Huntersville📍 Dallas📍 Fairfax Conjupro Biotherapeutics, Inc. · Tests: JMT108 DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. NCT05768178Phase 2, Phase 316 sites📍 Belfast📍 Birmingham📍 Bristol Cancer Research UK · Tests: Vemurafenib, Cobimetinib A Study of DEG6498 in Participants With Solid Tumors NCT07244835Phase 13 sites📍 Beijing📍 Beijing📍 Guangzhou Degron Therapeutics Co. · Tests: DEG6498 Ontario-wide Cancer TArgeted Nucleic Acid Evaluation NCT02906943n/a7 sites📍 Hamilton📍 Kingston📍 London University Health Network, Toronto
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy